DOI . ORG {}

Analyzed Page
Matching Content Categories
CMS
Monthly Traffic Estimate
How Does Doi.org Make Money
Keywords
Topics
Schema
External Links
Analytics And Tracking
Libraries
Hosting Providers
CDN Services

We began analyzing https://link.springer.com/article/10.1007/s12519-019-00229-3, but it redirected us to https://link.springer.com/article/10.1007/s12519-019-00229-3. The analysis below is for the second page.

Title[redir]:
Immunological pathogenesis and treatment of systemic lupus erythematosus | World Journal of Pediatrics
Description:
Background Systemic lupus erythematosis (SLE) is a complex and clinically heterogeneous autoimmune disease. A variety of immunological defects contribute to SLE, including dysregulated innate and adaptive immune response. A clearer understanding of the mechanisms driving disease pathogenesis combined with recent advances in medical science is predicted to enable accelerated progress towards improved SLE-personalized approaches to treatment. The aim of this review was to clarify the immunological pathogenesis and treatment of SLE. Data sources Literature reviews and original research articles were collected from database, including PubMed and Wanfang. Relevant articles about SLE were included. Results Breakdown of self-tolerance is the main pathogenesis of SLE. The innate and adaptive immune networks are interlinked with each other through cytokines, complements, immune complexes and kinases of the intracellular machinery. Treatments targeted at possible targets of immunity have been assessed in clinical trials. Most of them did not show better safety and efficacy than traditional treatments. However, novel targeting treatments are still being explored. Conclusions Dysregulated immune response plays a critical role in SLE, including innate immunity and adaptive immunity. Biologic agents that aim to specifically target abnormal immune processes were assessing and may bring new hope to SLE patients.

Matching Content Categories {📚}

Science
Health & Fitness
Education

Content Management System {📝}

What CMS is doi.org built with?

Custom-built

No common CMS systems were detected on Doi.org, and no known web development framework was identified.

Traffic Estimate {📈}

What is the average monthly size of doi.org audience?

🌠 Phenomenal Traffic: 5M - 10M visitors per month

Based on our best estimate, this website will receive around 5,000,019 visitors per month in the current month.
However, some sources were not loaded, we suggest to reload the page to get complete results.

check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush

How Does Doi.org Make Money? {💸}

We find it hard to spot revenue streams.

Some websites aren't about earning revenue; they're built to connect communities or raise awareness. There are numerous motivations behind creating websites. This might be one of them. Doi.org has a secret sauce for making money, but we can't detect it yet.

Keywords {🔍}

cells, sle, pubmed, google, scholar, lupus, cas, immune, patients, systemic, erythematosus, disease, activation, cell, bcell, pathogenesis, receptor, kinase, central, innate, protein, treatment, immunity, production, response, nets, role, antigen, activated, table, responses, studies, expression, baff, produce, activity, signaling, showed, immunol, complex, autoimmune, agents, target, nephritis, autoantibodies, ifn, ifnα, increased, interleukin, article,

Topics {✒️}

nacht leucine-rich-repeat protein/absent lupus-prone mrl/lpr mice organ-specific autoimmune diseases si-rui yang b-cell stimulating factor tumour necrosis factor-alpha anti-cd123 monoclonal antibodies t-cell-dependent antigen [59] treat b-cell lymphomas chimeric anti-cd20 antibody bcr b-cell receptor akt-gsk3beta signaling pathway anti-cd40l monoclonal antibodies anti-ifn monoclonal antibodies article download pdf anti-ds-dna concentrations bcl b-cell lymphoma full access stimulator-mediated signaling pathway improved sle-personalized approaches erm ezrin/radixin/moesin mei-ping lu cell-dependent inflammatory responses chemokine receptor cxcr3 reducing ds-dna levels interferon-alpha/beta system ubiquitin-mediated cellular functions induce b-cell proliferation enhancing tfh-cell responses systemic autoimmune diseases human–mouse chimeric mab activation-induced cell surface intensive short-term treatment neutrophil extracellular trap inhibits b-cell survival helper-cell subset assisting steroidal anti-inflammatory drugs b-targeted agents b-cell receptor receptor tyrosine kinase promotes b-cell activation neutrophil extracellular traps continuously produce ifn-α b-cell lymphoma 6 open label study zap-70 zeta-chain nzb/nzw mice active autoantibody-positive sle party related directly systemic lupus erythematosus

Schema {🗺️}

WebPage:
      mainEntity:
         headline:Immunological pathogenesis and treatment of systemic lupus erythematosus
         description:Systemic lupus erythematosis (SLE) is a complex and clinically heterogeneous autoimmune disease. A variety of immunological defects contribute to SLE, including dysregulated innate and adaptive immune response. A clearer understanding of the mechanisms driving disease pathogenesis combined with recent advances in medical science is predicted to enable accelerated progress towards improved SLE-personalized approaches to treatment. The aim of this review was to clarify the immunological pathogenesis and treatment of SLE. Literature reviews and original research articles were collected from database, including PubMed and Wanfang. Relevant articles about SLE were included. Breakdown of self-tolerance is the main pathogenesis of SLE. The innate and adaptive immune networks are interlinked with each other through cytokines, complements, immune complexes and kinases of the intracellular machinery. Treatments targeted at possible targets of immunity have been assessed in clinical trials. Most of them did not show better safety and efficacy than traditional treatments. However, novel targeting treatments are still being explored. Dysregulated immune response plays a critical role in SLE, including innate immunity and adaptive immunity. Biologic agents that aim to specifically target abnormal immune processes were assessing and may bring new hope to SLE patients.
         datePublished:2019-02-22T00:00:00Z
         dateModified:2019-02-22T00:00:00Z
         pageStart:19
         pageEnd:30
         license:http://creativecommons.org/licenses/by/4.0/
         sameAs:https://doi.org/10.1007/s12519-019-00229-3
         keywords:
            Immunological pathogenesis
            Systemic lupus erythematosis
            Treatment
            Pediatrics
            Pediatric Surgery
            Maternal and Child Health
            Intensive / Critical Care Medicine
            Surgery
            Imaging / Radiology
         image:
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs12519-019-00229-3/MediaObjects/12519_2019_229_Fig1_HTML.png
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs12519-019-00229-3/MediaObjects/12519_2019_229_Fig3_HTML.png
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs12519-019-00229-3/MediaObjects/12519_2019_229_Fig4_HTML.png
         isPartOf:
            name:World Journal of Pediatrics
            issn:
               1867-0687
               1708-8569
            volumeNumber:16
            type:
               Periodical
               PublicationVolume
         publisher:
            name:Springer Singapore
            logo:
               url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
               type:ImageObject
            type:Organization
         author:
               name:Lu Pan
               affiliation:
                     name:Jilin University
                     address:
                        name:Department of Pediatric Rheumatology and Allergy, The First Hospital, Jilin University, Changchun, China
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Mei-Ping Lu
               affiliation:
                     name:Zhejiang University School of Medicine
                     address:
                        name:Department of Allergy Immunology and Rheumatology, Children’s Hospital, Zhejiang University School of Medicine, Hangzhou, China
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Jing-Hua Wang
               affiliation:
                     name:Jilin University
                     address:
                        name:Department of Pediatric Rheumatology and Allergy, The First Hospital, Jilin University, Changchun, China
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Meng Xu
               affiliation:
                     name:Jilin University
                     address:
                        name:Department of Pediatric Rheumatology and Allergy, The First Hospital, Jilin University, Changchun, China
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Si-Rui Yang
               url:http://orcid.org/0000-0001-7984-3569
               affiliation:
                     name:Jilin University
                     address:
                        name:Department of Pediatric Rheumatology and Allergy, The First Hospital, Jilin University, Changchun, China
                        type:PostalAddress
                     type:Organization
               email:[email protected]
               type:Person
         isAccessibleForFree:1
         type:ScholarlyArticle
      context:https://schema.org
ScholarlyArticle:
      headline:Immunological pathogenesis and treatment of systemic lupus erythematosus
      description:Systemic lupus erythematosis (SLE) is a complex and clinically heterogeneous autoimmune disease. A variety of immunological defects contribute to SLE, including dysregulated innate and adaptive immune response. A clearer understanding of the mechanisms driving disease pathogenesis combined with recent advances in medical science is predicted to enable accelerated progress towards improved SLE-personalized approaches to treatment. The aim of this review was to clarify the immunological pathogenesis and treatment of SLE. Literature reviews and original research articles were collected from database, including PubMed and Wanfang. Relevant articles about SLE were included. Breakdown of self-tolerance is the main pathogenesis of SLE. The innate and adaptive immune networks are interlinked with each other through cytokines, complements, immune complexes and kinases of the intracellular machinery. Treatments targeted at possible targets of immunity have been assessed in clinical trials. Most of them did not show better safety and efficacy than traditional treatments. However, novel targeting treatments are still being explored. Dysregulated immune response plays a critical role in SLE, including innate immunity and adaptive immunity. Biologic agents that aim to specifically target abnormal immune processes were assessing and may bring new hope to SLE patients.
      datePublished:2019-02-22T00:00:00Z
      dateModified:2019-02-22T00:00:00Z
      pageStart:19
      pageEnd:30
      license:http://creativecommons.org/licenses/by/4.0/
      sameAs:https://doi.org/10.1007/s12519-019-00229-3
      keywords:
         Immunological pathogenesis
         Systemic lupus erythematosis
         Treatment
         Pediatrics
         Pediatric Surgery
         Maternal and Child Health
         Intensive / Critical Care Medicine
         Surgery
         Imaging / Radiology
      image:
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs12519-019-00229-3/MediaObjects/12519_2019_229_Fig1_HTML.png
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs12519-019-00229-3/MediaObjects/12519_2019_229_Fig3_HTML.png
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs12519-019-00229-3/MediaObjects/12519_2019_229_Fig4_HTML.png
      isPartOf:
         name:World Journal of Pediatrics
         issn:
            1867-0687
            1708-8569
         volumeNumber:16
         type:
            Periodical
            PublicationVolume
      publisher:
         name:Springer Singapore
         logo:
            url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
            type:ImageObject
         type:Organization
      author:
            name:Lu Pan
            affiliation:
                  name:Jilin University
                  address:
                     name:Department of Pediatric Rheumatology and Allergy, The First Hospital, Jilin University, Changchun, China
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Mei-Ping Lu
            affiliation:
                  name:Zhejiang University School of Medicine
                  address:
                     name:Department of Allergy Immunology and Rheumatology, Children’s Hospital, Zhejiang University School of Medicine, Hangzhou, China
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Jing-Hua Wang
            affiliation:
                  name:Jilin University
                  address:
                     name:Department of Pediatric Rheumatology and Allergy, The First Hospital, Jilin University, Changchun, China
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Meng Xu
            affiliation:
                  name:Jilin University
                  address:
                     name:Department of Pediatric Rheumatology and Allergy, The First Hospital, Jilin University, Changchun, China
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Si-Rui Yang
            url:http://orcid.org/0000-0001-7984-3569
            affiliation:
                  name:Jilin University
                  address:
                     name:Department of Pediatric Rheumatology and Allergy, The First Hospital, Jilin University, Changchun, China
                     type:PostalAddress
                  type:Organization
            email:[email protected]
            type:Person
      isAccessibleForFree:1
["Periodical","PublicationVolume"]:
      name:World Journal of Pediatrics
      issn:
         1867-0687
         1708-8569
      volumeNumber:16
Organization:
      name:Springer Singapore
      logo:
         url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
         type:ImageObject
      name:Jilin University
      address:
         name:Department of Pediatric Rheumatology and Allergy, The First Hospital, Jilin University, Changchun, China
         type:PostalAddress
      name:Zhejiang University School of Medicine
      address:
         name:Department of Allergy Immunology and Rheumatology, Children’s Hospital, Zhejiang University School of Medicine, Hangzhou, China
         type:PostalAddress
      name:Jilin University
      address:
         name:Department of Pediatric Rheumatology and Allergy, The First Hospital, Jilin University, Changchun, China
         type:PostalAddress
      name:Jilin University
      address:
         name:Department of Pediatric Rheumatology and Allergy, The First Hospital, Jilin University, Changchun, China
         type:PostalAddress
      name:Jilin University
      address:
         name:Department of Pediatric Rheumatology and Allergy, The First Hospital, Jilin University, Changchun, China
         type:PostalAddress
ImageObject:
      url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
      name:Lu Pan
      affiliation:
            name:Jilin University
            address:
               name:Department of Pediatric Rheumatology and Allergy, The First Hospital, Jilin University, Changchun, China
               type:PostalAddress
            type:Organization
      name:Mei-Ping Lu
      affiliation:
            name:Zhejiang University School of Medicine
            address:
               name:Department of Allergy Immunology and Rheumatology, Children’s Hospital, Zhejiang University School of Medicine, Hangzhou, China
               type:PostalAddress
            type:Organization
      name:Jing-Hua Wang
      affiliation:
            name:Jilin University
            address:
               name:Department of Pediatric Rheumatology and Allergy, The First Hospital, Jilin University, Changchun, China
               type:PostalAddress
            type:Organization
      name:Meng Xu
      affiliation:
            name:Jilin University
            address:
               name:Department of Pediatric Rheumatology and Allergy, The First Hospital, Jilin University, Changchun, China
               type:PostalAddress
            type:Organization
      name:Si-Rui Yang
      url:http://orcid.org/0000-0001-7984-3569
      affiliation:
            name:Jilin University
            address:
               name:Department of Pediatric Rheumatology and Allergy, The First Hospital, Jilin University, Changchun, China
               type:PostalAddress
            type:Organization
      email:[email protected]
PostalAddress:
      name:Department of Pediatric Rheumatology and Allergy, The First Hospital, Jilin University, Changchun, China
      name:Department of Allergy Immunology and Rheumatology, Children’s Hospital, Zhejiang University School of Medicine, Hangzhou, China
      name:Department of Pediatric Rheumatology and Allergy, The First Hospital, Jilin University, Changchun, China
      name:Department of Pediatric Rheumatology and Allergy, The First Hospital, Jilin University, Changchun, China
      name:Department of Pediatric Rheumatology and Allergy, The First Hospital, Jilin University, Changchun, China

External Links {🔗}(353)

Analytics and Tracking {📊}

Google Tag Manager

Libraries {📚}

Clipboard.js
Prism.js

Emails and Hosting {✉️}

Mail Servers:

mx.zoho.eu
mx2.zoho.eu
mx3.zoho.eu

Name Servers:

josh.ns.cloudflare.com
zita.ns.cloudflare.com

CDN Services {📦}

Crossref

4.82s.